Vanda Pharmaceuticals (VNDA) Assets (2010 - 2026)
Vanda Pharmaceuticals' Assets came in at $412.47 million for Q2 2026, down 34.0% from $624.75 million a year earlier and down 4.9% from the prior quarter.
Powered by 
Analysis
Vanda Pharmaceuticals (VNDA) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Vanda Pharmaceuticals' Assets was $488.95 million, down 25.5% from FY2024.
- Assets carries a five-year compound annual growth rate of -1.7% (FY2020 to FY2025).
- Going back by year, Assets was $656.2 million in FY2024 (+1.2%), $648.44 million in FY2023 (+2.2%), $634.25 million in FY2022 (+6.8%) and $593.79 million in FY2021 (+11.3%).
- The Q2 2026 figure represents the lowest quarterly Assets since Q2 2019.
- Year-over-year, Assets has declined for six consecutive quarters, with an average decline of 12.9% over the last eight quarters.
- The fastest year-over-year change in Assets over five years came in Q3 2021 (growth of 12.4%), and the weakest in Q2 2026 (a decline of 34.0%).
- Business Quant data shows VNDA's Assets at $433.53 million (Q1 2026), $488.95 million (Q4 2025) and $601.14 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Vanda Pharmaceuticals | 279.91 Mn | -650.03 Mn | 46.97 Mn | 412.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 412.47 Mn |
| Mar 31, 2026 | 433.53 Mn |
| Dec 31, 2025 | 488.95 Mn |
| Sep 30, 2025 | 601.14 Mn |
| Jun 30, 2025 | 624.75 Mn |
| Mar 31, 2025 | 631.94 Mn |
| Dec 31, 2024 | 656.20 Mn |
| Sep 30, 2024 | 645.12 Mn |
| Jun 30, 2024 | 651.37 Mn |
| Mar 31, 2024 | 652.68 Mn |
| Dec 31, 2023 | 648.44 Mn |
| Sep 30, 2023 | 641.61 Mn |
| Jun 30, 2023 | 641.68 Mn |
| Mar 31, 2023 | 644.53 Mn |
| Dec 31, 2022 | 634.25 Mn |
| Sep 30, 2022 | 621.79 Mn |
| Jun 30, 2022 | 609.10 Mn |
| Mar 31, 2022 | 603.56 Mn |
| Dec 31, 2021 | 593.79 Mn |
| Sep 30, 2021 | 579.77 Mn |
API Access
Vanda Pharmaceuticals Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=VNDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "VNDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=VNDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();